ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Quest PharmaTech Inc

Quest PharmaTech Inc (QPT)

0.03
0.005
(20.00%)
Cerrado 22 Diciembre 3:00PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.03
Postura de Compra
0.025
Postura de Venta
0.03
Volume Operado de la Acción
67,200
0.025 Rango del Día 0.03
0.015 Rango de 52 semanas 0.07
Capitalización de Mercado [m]
Precio Anterior
0.025
Precio de Apertura
0.025
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
33,097
Acciones en circulación
169,129,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.69
Beneficio por acción (BPA)
-0.02
turnover
-
Beneficio neto
-3.02M

Acerca de Quest PharmaTech Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Edmonton, Alberta, Can
Fundado
-
Quest PharmaTech Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker QPT. The last closing price for Quest PharmaTech was $0.03. Over the last year, Quest PharmaTech shares have traded in a share price range of $ 0.015 to $ 0.07.

Quest PharmaTech currently has 169,129,000 shares in issue. The market capitalisation of Quest PharmaTech is $4.23 million. Quest PharmaTech has a price to earnings ratio (PE ratio) of -1.69.

QPT Últimas noticias

Quest PharmaTech Announces Results from AGM

EDMONTON, Alberta, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its October 8, 2024 annual general meeting of...

Quest PharmaTech Receives U.S. $2 Million for its Immuno-Photodynamic Therapy Assets

Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”), a pharmaceutical company developing and commercializing products to improve the quality of life, today announced the sale of its...

Quest PharmaTech to Market and Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creato...

Quest PharmaTech to Market and Distribute Premium Anti-Wrinkle Skin Care Product, Bellus Skin™; Dr. Jacqueline Shan, Creator of COLD FX®, to Assist PR Newswire EDMONTON, Oct. 22, 2014...

Quest PharmaTech Completes Patient Enrollment in Phase IIb Study of Oregovomab for the Immunotherapy of Ovarian Cancer

Quest PharmaTech Completes Patient Enrollment in Phase IIb Study of Oregovomab for the Immunotherapy of Ovarian Cancer PR Newswire EDMONTON, June 9, 2014 TSX Venture: QPT EDMONTON, June 9, 2014...

Quest PharmaTech strengthens its Antibody Immunotherapy Technology by licensing anti-MUC1 IgE Technology from Stanford Univer...

Quest PharmaTech strengthens its Antibody Immunotherapy Technology by licensing anti-MUC1 IgE Technology from Stanford University; Researchers to present late-breaking data at the 28th Annual...

Quest PharmaTech Establishes Joint Venture with Korean-Based AD Biotech Co., Ltd. to Develop Immunotherapeutic Products for C...

Quest PharmaTech Establishes Joint Venture with Korean-Based AD Biotech Co., Ltd. to Develop Immunotherapeutic Products for Cancer PR Newswire EDMONTON, July 23, 2013 TSX Venture: QPT EDMONTON...

Quest PharmaTech Signs Exclusive License Agreement with UCLA for anti - PSA IgE Technology; UCLA researchers to present anti ...

Quest PharmaTech Signs Exclusive License Agreement with UCLA for anti - PSA IgE Technology; UCLA researchers to present anti - PSA IgE preclinical data at the 2013 American Association for Cancer...

Quest PharmaTech Enrolls 40th Patient in its Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial for Ovarian Ca...

Quest PharmaTech Enrolls 40th Patient in its Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial for Ovarian Cancer in Italy and the U.S. #ReleaseContent TABLE {...

Quest PharmaTech Acquires Immunoglobulin E Technology to Strengthen its Combination Therapy Approach for the Treatment of Can...

Quest PharmaTech Acquires Immunoglobulin E Technology to Strengthen its Combination Therapy Approach for the Treatment of Cancer PR Newswire EDMONTON, Oct. 2, 2012 TSX Venture: QPT EDMONTON, Oct...

Quest PharmaTech Updates Progress of Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in Italy

Quest PharmaTech Updates Progress of Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in Italy PR Newswire EDMONTON, July 10, 2012 TSX Venture: QPT EDMONTON, July 10, 2012...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.030.030.02510000.025CS
4-0.005-14.28571428570.0350.040.025172250.02849057CS
120.005200.0250.040.025330970.02899576CS
260.005200.0250.040.015387280.02469774CS
52-0.03-500.060.070.015297580.02822991CS
156-0.07-700.10.1650.015204810.05769964CS
260-0.075-71.42857142860.1050.320.015247600.09512672CS

QPT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Quest PharmaTech?
El precio actual de las acciones de Quest PharmaTech es $ 0.03
¿Cuántas acciones de Quest PharmaTech están en circulación?
Quest PharmaTech tiene 169,129,000 acciones en circulación
¿Cuál es la capitalización de mercado de Quest PharmaTech?
La capitalización de mercado de Quest PharmaTech es CAD 4.23M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Quest PharmaTech?
Quest PharmaTech ha negociado en un rango de $ 0.015 a $ 0.07 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Quest PharmaTech?
El ratio precio/beneficio de Quest PharmaTech es -1.69
¿Cuál es la moneda de reporte de Quest PharmaTech?
Quest PharmaTech presenta sus resultados financieros en CAD
¿Cuál es el último beneficio anual de Quest PharmaTech?
El último beneficio anual de Quest PharmaTech es CAD -3.02M
¿Cuál es la dirección registrada de Quest PharmaTech?
La dirección registrada de Quest PharmaTech es 4342 - 97 STREET NW,EDMONTON, EDMONTON, ALBERTA, T6E 5R9
¿Cuál es la dirección del sitio web de Quest PharmaTech?
La dirección del sitio web de Quest PharmaTech es www.questpharmatech.com
¿En qué sector industrial opera Quest PharmaTech?
Quest PharmaTech opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
GNFIGenifi Inc
$ 0.015
(200.00%)
4k
GHR.HGolden Harp Resources Inc
$ 0.10
(185.71%)
2.73k
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
2k
NICKNickelex Resource Corporation
$ 0.01
(100.00%)
1.1k
GAR.HGreen Arrow Resources Inc
$ 0.045
(80.00%)
1,000
CBAChampion Bear Resources Ltd
$ 0.015
(-62.50%)
101k
NIKL.HGK Resources LTD
$ 0.045
(-50.00%)
1,000
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
3.34M
WWTWater Ways Technologies Inc
$ 0.005
(-50.00%)
106.09k
COOOstrom Climate Solutions Inc
$ 0.05
(-50.00%)
109.5k
QNCQuantum Emotion Corp
$ 0.435
(26.09%)
7.32M
GXUGoviEx Uranium Inc
$ 0.055
(10.00%)
4.68M
FUUF3 Uranium Corp
$ 0.25
(6.38%)
3.64M
AUUAALUULA Composites Inc
$ 0.05
(0.00%)
3.63M
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
3.34M
brooklyn13 brooklyn13 3 minutos hace
Now show us a picture of your festive menorah.
tkg tkg 3 minutos hace
The optical transceiver market is 33 B in 2029, in this case it means 33/45 =0,733 or 73 % of $ 150 around $ 110 -120.
Oops little ( unbelievable big) difference.

I'm always so grateful for your valuable input jeunke22!
LWLG
capgain capgain 6 minutos hace
"TOO MANY COMMERCIALS, sheesh!" I agree.
chrismiss_everyday chrismiss_everyday 12 minutos hace
https://www.anavex.com/post/anavex-life-sciences-and-partex-group-announce-strategic-partnership

Jun 27, 2023

Anavex Life Sciences and Partex Group Announce Strategic Partnership to Leverage AI for Drug Development and Healthcare Sales Marketing Building a Patient-Centr
AVXL
copytele copytele 13 minutos hace
RGTI https://youtu.be/QmJGGNZ06RY
RGTI
capgain capgain 17 minutos hace
Look at you, nice Saturday.
copytele copytele 19 minutos hace
RGTI https://youtu.be/QmJGGNZ06RY
RGTI
borysek borysek 22 minutos hace
one good financial report can change a lot but it will never happen ... in the weed store close to my house called "The spirit Leaf " they stopped selling CGC products - NO DEMAND ...
WEED
Investor2014 Investor2014 24 minutos hace
Yeah and the $SAVA CEO according to you is and now was much better.
SAVA
ksquared ksquared 27 minutos hace
Thanks for the heads up, Bull.
I still haven't figured out how to pause the map and figure out the timing.
Good old (in)Accuweather predicts snow Tuesday morning.
It'll be warmer (high 39) so the paved surfaces should clear up nicely.
Alexulf Alexulf 28 minutos hace
Merry Christmas and Happy New Year! Let the peace in and recover to 2025,
we are in for big AITX things, see the website for full information;

https://aitx.ai/



GLTA
AITX
walterc walterc 30 minutos hace
for completness sake

you are one of these Belgians

and for your info.
i think you would be extremely happy with the profits made at lwlg even at these cratered prices.

so speak for yourself
LWLG
goldbarren58 goldbarren58 36 minutos hace
LOL Vic doesnt dirty his hands

he let Clayton or that navy guy do it
NWPN
Bull_Dolphin Bull_Dolphin 37 minutos hace
Good morning kk. Looks like your going to have a white Christmas:

https://www.wpc.ncep.noaa.gov/basicwx/day0-7loop.html
ElectricMountain53 ElectricMountain53 39 minutos hace
Doesn't take away the fact lots of belgians have invested in the worst performing stocks over the last decade. Niocorp, Lightwave to name a few LOL
LWLG
Frankestin Frankestin 44 minutos hace
Just think, in July, when was this offer closed, it was at 0.50 and there was no 74 day letter imminent!
TNXP
ksquared ksquared 49 minutos hace
Wow! Great way to start the day. Thanks and GM, Bull.
walterc walterc 53 minutos hace
for your information

Jeunke is Dutch nott (lol) Belgian.
LWLG
ksquared ksquared 53 minutos hace
Good Morning, Mr. Gmenfancicle. We're in the tropics compared to you. We're still in double digits.
The joy of single ones arrives tonight. Fortunately we're due for a warm up on Tuesday.
To me, this snow was beautiful and easily managed. It lent the perfect atmo
Bull_Dolphin Bull_Dolphin 54 minutos hace
Tree topper:

https://x.com/KarluskaP/status/1870453214614892608
copytele copytele 56 minutos hace
https://youtu.be/QmJGGNZ06RY
RGTI
ksquared ksquared 59 minutos hace
GM, MG. So glad to read you got yourself a room with HEAT.
It's a frosty 14° up here in the NW corner of nj. Word has it we'll get up to a toasty 24 today and down to 4 tonight. Sleeping in your truck would be insanity.
Stay safe and warm.
Peter J Peter J 1 hora hace
Mr. "beat around the bush" ...

.... looking out for the gullible investor here, on the, by it OTC Markets Group itself labelled "Buyer Beware!!" 'Skull and Bones' Expert market.

*There is no interest in ERHC, not even by insiders
*There is no possibility to buy t
ERHE

Su Consulta Reciente

Delayed Upgrade Clock